Afuco™ Anti-S. aureus ClfA ADCC Therapeutic Antibody (Tefibazumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibodyto Human S. aureus Tefibazumab (marketed under the brand name Aurexis) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in patient with cystic fibrosis and of methicillin-resistant S. aureus.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-029 |
| Pricing | Inquiry |
| Host | Human |
| Target | S. aureus ClfA |
| Species Reactivity | S. aureus |
| Type | ADCC enhanced antibody |
| Applications | IP, IF, FuncS, FC, Neut, ELISA |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |